|
Re: Debt
|
2
|
Zenith Epigenetics
|
Apr 03, 2022 01:04PM
|
|
Re: Right of first refusal
|
2
|
Resverlogix Corp.
|
Mar 03, 2019 01:50PM
|
|
Re: Thoughts?
|
2
|
Resverlogix Corp.
|
Apr 06, 2021 09:51AM
|
|
Re: What we know and what we don't.....
|
2
|
Resverlogix Corp.
|
May 16, 2019 05:20PM
|
|
Re: Zenith-Oncology Pipeline
|
2
|
Zenith Epigenetics
|
Mar 19, 2021 06:49AM
|
|
Re: Hepa Links up close to the max 10% in early trading
|
2
|
Resverlogix Corp.
|
May 01, 2024 09:14AM
|
|
Re: Resverlogix Announces Apabetalone Prior to SARS-CoV-2 (COVID-19) Exposure Reduces Viral Infection – Confirms Plans for COVID-19 Clinical Trial
|
2
|
Resverlogix Corp.
|
Dec 22, 2020 09:40AM
|
|
Re: Secured $6M Convertable Debenture
|
2
|
Resverlogix Corp.
|
Apr 16, 2024 02:40PM
|
|
Re: Why? How?
|
2
|
Resverlogix Corp.
|
Sep 20, 2024 06:23AM
|
|
Re: Talk about getting.....
|
2
|
Resverlogix Corp.
|
Jun 11, 2019 12:35PM
|
|
Re: Recent article; published in Clinical Epigenetics
|
2
|
Resverlogix Corp.
|
Jan 13, 2023 02:04PM
|
|
Re: maybe Zen will go first?
|
2
|
Resverlogix Corp.
|
May 04, 2020 01:39PM
|
|
Re: K2
|
2
|
Resverlogix Corp.
|
Apr 10, 2021 10:39AM
|
|
Re: If BP buys Apabetalone,...
|
2
|
Resverlogix Corp.
|
Nov 05, 2019 04:46PM
|
|
Re: Number of outstanding warrants + impact
|
2
|
Resverlogix Corp.
|
Nov 26, 2019 06:14AM
|
|
Re: Back to the FDA
|
2
|
Resverlogix Corp.
|
Oct 04, 2019 07:32AM
|
|
Re: AHA 2018
|
2
|
Resverlogix Corp.
|
Nov 12, 2018 08:07AM
|
|
Re: Value
|
2
|
Resverlogix Corp.
|
Feb 04, 2022 06:02PM
|
|
Re: Dr. Mark Day interview with Proactive Investors at BIO CEO
|
2
|
BIOASIS TECHNOLOGIES INC
|
Feb 12, 2019 02:09PM
|
|
Re: pfizer
|
2
|
Resverlogix Corp.
|
Dec 15, 2020 04:55PM
|
